CorMedix Inc. (CRMD) insider trading.
In Q3 2026, insiders at CorMedix Inc. reported 4 non-derivative transactions on 4 Forms 3, 4 and 5: 0 open-market purchases and 0 sales.
- Transactions
- 4
- Purchases (P)
- 0
- Sales (S)
- 0
- Net shares, P minus S
- 0
- Insiders
- 4
- Last filed
- 2026-09-18
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Dillione Janet | Director | 1 | 0 | 0 |
| Zelnick Kaufman Beth | Officer · Chief Legal Officer | 1 | 0 | 0 |
| Hurlburt Elizabeth | Officer · Chief Operating Officer | 1 | 0 | 0 |
| Blum Susan | Officer · Chief Financial Officer | 1 | 0 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-18 | Dillione Janet | M (A) | 48,909 | — | 117,835 | Form 4 |
| 2026-08-29 | Zelnick Kaufman Beth | F (D) | 8,424 | $8.3 | 260,684 | Form 4 |
| 2026-08-29 | Hurlburt Elizabeth | F (D) | 8,076 | $8.3 | 270,463 | Form 4 |
| 2026-08-29 | Blum Susan | F (D) | 8,424 | $8.3 | 124,315 | Form 4 |
Transaction codes in this quarter
Get CRMD insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1410098&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · CRMD company page · CorMedix Inc. on SEC.gov
Questions
Are insiders buying or selling CorMedix Inc. (CRMD)?
In Q3 2026, insiders at CorMedix Inc. reported 4 non-derivative transactions on 4 Forms 3, 4 and 5: 0 open-market purchases and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these CorMedix Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/crmd.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.